Q301--Strand-Specific RNA-Sequencing Services
Veterans Affairs · 241-NETWORK CONTRACT OFFICE 01 (36C241)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C24126Q0788 in this department, oldest first.
- Aug 31, 2026 · this noticeCombined Synopsis/Solicitation
- Sep 3, 2026Combined Synopsis/SolicitationOpen
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
COMBINED SYNOPSIS/SOLICITATION STRAND-SPECIFIC RNA-SEQUENCING SERVICES This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with FAR Part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued. Solicitation number 36C24126Q0788 is issued as a Request for Quotation (RFQ) for Strand-Specific RNA-Sequencing Services. This acquisition is set aside 100 percent for small business concerns. This solicitation incorporates provisions and clauses by reference. The… (show all)
full text of provisions and clauses may be accessed electronically at www.acquisition.gov. Solicitation Number 36C24126Q0788 Set-Aside 100% Total Small Business NAICS 541714 - Research and Development in Biotechnology (except Nanobiotechnology) PSC Q301 - Medical - Reference Laboratory Testing Contract Type Firm-Fixed-Price Questions Due September 3, 2026 at 11:00 AM Eastern Time (ET) Quotes Due September 10, 2026 at 11:00 AM Eastern Time (ET) (ii) LINE ITEMS CLIN Description Qty Unit Unit Price Total Price 0001 Strand-Specific RNA-Sequencing Services in accordance with Attachment 1, Performance Work Statement 269 EA $________ $________ The quoted price shall include all labor, personnel, equipment, laboratory services, materials, supplies, sample processing, sequencing, quality-control activities, data preparation, delivery, shipping, overhead, and all other costs necessary to perform the complete requirement. (iii) DESCRIPTION OF REQUIREMENT The Department of Veterans Affairs (VA), Network Contracting Office 1 (NCO 1), requires Strand-Specific RNA-Sequencing Services in support of the VA Bedford Healthcare System. The requirement is for sequencing of 269 Government-furnished human choroid plexus total RNA samples. Services include sample quality-control assessment, strand-specific rRNA depletion-based library preparation, Illumina paired-end 2x150bp sequencing at 60 million read pairs per sample (approximately 120 million total reads per sample), sequencing quality-control assessment and reporting, and delivery of FASTQ files and associated quality-control reports. Complete technical requirements are provided in Attachment 1 - Performance Work Statement (PWS). (iv) DELIVERY, PERFORMANCE, AND ACCEPTANCE Period of Performance: One year from date of award. Sample QC, library preparation, sequencing, quality-control reporting, and final data delivery shall be completed within 23-28 business days following receipt of all 269 samples as one batch, in accordance with the PWS. Place of Performance: The successful Contractor's laboratory facility or facilities identified in its quotation. Government-furnished samples will be shipped from the VA Bedford Healthcare System to the Contractor's designated laboratory facility. Acceptance and data delivery shall be in accordance with the PWS. Physical hard-drive delivery is the standard method. Secure electronic/cloud-based delivery may be authorized by the Government when the proposed method satisfies applicable VA information-security requirements. (v) SOLICITATION PROVISIONS 52.212-1 - Instructions to Offerors-Commercial Products and Commercial Services (DEVIATION) 52.212-2 - Evaluation-Commercial Products and Commercial Services (DEVIATION) 52.203-18 - Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements or Statements-Representation 52.204-7 - System for Award Management-Registration (DEVIATION) 52.219-1 - Small Business Program Representations (DEVIATION) 52.229-11 - Tax on Certain Foreign Procurements-Notice and Representation (DEVIATION), 52.252-1 - Solicitation Provisions Incorporated by Reference 52.252-5 - Authorized Deviations in Provisions 852.215-72 - Notice of Intent to Re-solicit ADDENDUM TO FAR 52.212-1 - QUOTATION SUBMISSION REQUIREMENTS Quoters shall submit a complete quotation containing the following: 1. Technical Capability Statement The Quoter shall submit a Technical Capability Statement not to exceed five (5) pages demonstrating its capability to successfully perform the requirements of the PWS. At a minimum, the statement shall address: Relevant experience performing strand-specific, rRNA-depleted RNA sequencing at a comparable scale and sequencing depth, including experience processing degraded or post-mortem human tissue-derived RNA. Proposed strand-specific RNA-sequencing methodology, including rRNA depletion and library preparation. Illumina sequencing platform(s) proposed and capability to perform paired-end 2x150bp sequencing at 60 million read pairs per sample (approximately 120 million total reads per sample) for all 269 samples. Quality-control procedures and capability to achieve at least 85% of bases at Phred quality score Q30 or greater. Capability to complete the required services and final data delivery within 23-28 business days following receipt of all 269 samples as one batch. Laboratory Location and Performance Approach: Identify the laboratory facility or facilities where sample QC, library preparation, sequencing, and related laboratory services will be performed. The Quoter shall identify which portions of the requirement will be performed directly by the Quoter and which, if any, will be performed by a subcontractor or third-party laboratory. For any proposed subcontractor or third-party laboratory, identify the entity, its location, and the specific services it will perform. Capability to provide FASTQ files and associated quality-control reports in accordance with the PWS. The Technical Capability Statement shall contain sufficient information for the Government to determine technical acceptability. Merely restating the PWS requirements or stating that the Quoter will comply, without sufficient supporting information demonstrating capability, may be insufficient to establish technical acceptability. 2. Price Quotation CLIN 0001 Unit Price: $________ per sample Quantity: 269 EA Total Price: $________. The quotation shall be Firm-Fixed-Price. 3. Business Information Provide the legal business name and address, point of contact, telephone number, email address, Unique Entity Identifier (UEI), CAGE Code, and small-business status under NAICS 541714. The Quoter shall maintain the SAM.gov registration required for award. ADDENDUM TO FAR 52.212-2 - EVALUATION AND BASIS FOR AWARD The Government will evaluate quotations utilizing the simplified acquisition procedures of RFO FAR Part 12. Award will be made to the responsible Quoter submitting the lowest-priced technically acceptable quotation. Factor 1 - Technical Capability Technical Capability will be evaluated on an Acceptable/Unacceptable basis. Acceptable means the Technical Capability Statement demonstrates the Quoter's capability to successfully perform all material technical requirements of the PWS. Unacceptable means the statement fails to demonstrate capability to successfully perform one or more material technical requirements. A quotation receiving an Unacceptable technical rating will not be eligible for award. Factor 2 - Price The Government will evaluate the total quoted price for the complete requirement. The Contracting Officer will determine whether the quoted price is fair and reasonable. (vi) CONTRACT CLAUSES 52.212-4 - Contract Terms and Conditions-Commercial Products and Commercial Services (DEVIATION) 52.203-17 - Contractor Employee Whistleblower Rights 52.203-19 - Prohibition on Requiring Certain Internal Confidentiality Agreements or Statements 52.204-13 - System for Award Management-Maintenance (DEVIATION) 52.209-6 - Protecting the Government's Interest When Subcontracting With Contractors Debarred, Suspended, Proposed for Debarment, or Voluntarily Excluded 52.209-10 - Prohibition on Contracting With Inverted Domestic Corporations 52.219-6 - Notice of Total Small Business Set-Aside (DEVIATION) 52.222-36 - Equal Opportunity for Workers with Disabilities (DEVIATION)
Who won similar work
123 award notices on SAM.gov in the last 24 months. Matched by: Same agency (Veterans Affairs), same product/service code (PSC) Q301.
Single-winner award sizes (123): middle half $275K to $2.9M, median $695K; range $19K to $46.0M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| QUEST DIAGNOSTICS INCORPORATED · $DGX · $9.3B | 20 | $202.4M | Aug 6, 2026 |
| LABORATORY CORPORATION | 15 | $69.7M | Oct 1, 2026 |
| I-2-I Solutions, Inc. | 4 | $2.4M | Oct 2, 2026 |
| WINERGY LLC | 4 | $1.1M | Sep 11, 2025 |
| OREGON HEALTH & SCIENCE UNIVERSITY Portland OR 97239 USA | 3 | $18.7M | Jun 17, 2026 |
| CYTOPATH BIOPSY LAB INC | 3 | $1.5M | Sep 22, 2026 |
| VERACYTE LABS SD CORPORATION · $VCYT · $361.1M | 3 | $859K | Jun 2, 2026 |
| UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE Seattle WA 98195 USA | 2 | $9.7M | Dec 2, 2025 |
| BECKMAN COULTER, INC | 2 | $5.0M | Nov 28, 2025 |
| ROCHE DIAGNOSTICS CORPORATION | 2 | $2.6M | Nov 13, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $DGX reported $9.3B revenue in FY2025. The median single-winner award in these 123 past awards, $695K, is under 0.1% of that. 10-K
- $VCYT reported $361.1M revenue in FY2025. The median single-winner award in these 123 past awards, $695K, is 0.2% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Oct 6, 2026MINNESOTA VALLEY TESTING LABORATORIES, INC.$452KQ301--Water Quality Laboratory Testing Services
- Oct 2, 2026I-2-I Solutions, Inc.$1.7MQ301--Legionella Testing VISN 6
- Oct 1, 2026BITSCOPIC INC$475KSoftware License - Oncology Informatics Module for PraediGene Software Platform
- Oct 1, 2026LABORATORY CORPORATION$1.3MQ301--CYTOPATHOLOGY AND NEXT GENERATION SEQUENCING TESTING SERVICES
- Sep 29, 2026LABORATORY CORPORATION$7.3MAward Notice - Reference Lab Testing Services
- Sep 25, 2026THE JOHNS HOPKINS UNIVERSITY Baltimore MD 21218 USA$624KSpecialized Biomarker Lab for TRACTS
- Sep 22, 2026CYTOPATH BIOPSY LAB INC$1.0MQ301-- Molecular Thyroid Testing
- Sep 16, 2026EXOSOME DIAGNOSTICS INC$1.1MQ301--Base Year | 36C259-26-AP-1918 | Prostate Testing Non-Invasive | VISN Contract
- Sep 8, 2026UPMC Presbyterian Shadyside Pittsburgh PA 15213 USA$681KReference Laboratory Testing
- Sep 1, 2026VETERANS COMMAND, LLC$132KQ301-- Transcription Services Washington DC VAMC
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $22K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 2 of the past winners are listed companies
- 0 insider buys and 5 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.